Apotheek Verbanck: what changed
Apotheek Verbanck
Largest movements
- Current investments +€947,000
up €947,000 (+1,214%), from €78,000 to €1.0m
- Cash -€915,134
down €915,134 (-89.2%), from €1.0m to €110,425
mainly Current investments (-€947,000) and Contributions, distributions and other (-€129,675)
- Receivables within one year +€43,218
up €43,218 (+73.5%), from €58,790 to €102,009
of which Trade receivables: +€40,828
- Tangible fixed assets +€20,254
new in 2025: €20,254
of which Furniture and vehicles: +€16,959
- Other debts +€102,732
up €102,732 (+749%), from €13,713 to €116,444
- Reserves -€25,940
down €25,940 (-2.2%), from €1.2m to €1.2m
of which Distributable reserves: -€25,940
- Trade debts +€24,247
up €24,247 (+43.4%), from €55,871 to €80,118
- Staff costs +€54,971
new in 2025: €54,971
- Financial income +€48,927
up €48,927 (+1,797%), from €2,723 to €51,649
- Taxes -€20,661
down €20,661 (-56.2%), from €36,793 to €16,133
- Gross operating margin -€16,102
down €16,102 (-11.0%), from €146,381 to €130,279
- Other operating charges +€2,003
up €2,003 (+175%), from €1,143 to €3,145
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,319,411 | €1,420,805 | +€101,394 | +7.7% |
| Fixed assets | 21/28 | - | €20,254 | +€20,254 | |
| Tangible fixed assets | 22/27 | - | €20,254 | +€20,254 | |
| Plant, machinery and equipment | 23 | - | €3,295 | +€3,295 | |
| Furniture and vehicles | 24 | - | €16,959 | +€16,959 | |
| Current assets | 29/58 | €1,319,411 | €1,400,551 | +€81,140 | +6.1% |
| Stocks and contracts in progress | 3 | €146,938 | €142,437 | -€4,502 | -3.1% |
| Stocks | 30/36 | €146,938 | €142,437 | -€4,502 | -3.1% |
| Amounts receivable within one year | 40/41 | €58,790 | €102,009 | +€43,218 | +73.5% |
| Trade receivables | 40 | €55,229 | €96,056 | +€40,828 | +73.9% |
| Other amounts receivable | 41 | €3,562 | €5,952 | +€2,390 | +67.1% |
| Current investments | 50/53 | €78,000 | €1,025,000 | +€947,000 | +1,214% |
| Cash at bank and in hand | 54/58 | €1,025,559 | €110,425 | -€915,134 | -89.2% |
| Deferred charges and accrued income | 490/1 | €10,123 | €20,681 | +€10,558 | +104% |
| Total equity and liabilities | 10/49 | €1,319,411 | €1,420,805 | +€101,394 | +7.7% |
| Equity | 10/15 | €1,238,122 | €1,212,182 | -€25,940 | -2.1% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €1,176,122 | €1,150,182 | -€25,940 | -2.2% |
| Non-distributable reserves | 130/1 | €30,250 | €30,250 | = | 0.0% |
| Legal reserve | 130 | €30,250 | €30,250 | = | 0.0% |
| Distributable reserves | 133 | €1,145,872 | €1,119,932 | -€25,940 | -2.3% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €81,289 | €208,623 | +€127,334 | +157% |
| Amounts payable within one year | 42/48 | €78,268 | €204,175 | +€125,907 | +161% |
| Trade debts | 44 | €55,871 | €80,118 | +€24,247 | +43.4% |
| Suppliers | 440/4 | €55,871 | €80,118 | +€24,247 | +43.4% |
| Taxes, remuneration and social security | 45 | €8,684 | €7,612 | -€1,071 | -12.3% |
| Taxes | 450/3 | €5,684 | €0 | -€5,684 | -100% |
| Remuneration and social security | 454/9 | €3,000 | €7,612 | +€4,612 | +154% |
| Other amounts payable | 47/48 | €13,713 | €116,444 | +€102,732 | +749% |
| Accrued charges and deferred income | 492/3 | €3,021 | €4,448 | +€1,427 | +47.2% |
| Remuneration, social security and pensions | 62 | - | €54,971 | +€54,971 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €1,684 | +€1,684 | |
| Other operating charges | 640/8 | €1,143 | €3,145 | +€2,003 | +175% |
| Gross operating margin | 9900 | €146,381 | €130,279 | -€16,102 | -11.0% |
| Operating profit (loss) | 9901 | €145,238 | €70,478 | -€74,760 | -51.5% |
| Financial income | 75/76B | €2,723 | €51,649 | +€48,927 | +1,797% |
| Recurring financial income | 75 | €2,723 | €51,649 | +€48,927 | +1,797% |
| Financial charges | 65/66B | €3,284 | €2,260 | -€1,024 | -31.2% |
| Recurring financial charges | 65 | €3,284 | €2,260 | -€1,024 | -31.2% |
| Profit (loss) for the period before taxes | 9903 | €144,677 | €119,868 | -€24,810 | -17.1% |
| Income taxes | 67/77 | €36,793 | €16,133 | -€20,661 | -56.2% |
| Profit (loss) for the period | 9904 | €107,884 | €103,735 | -€4,149 | -3.8% |
| Profit (loss) for the period to be appropriated | 9905 | €107,884 | €103,735 | -€4,149 | -3.8% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.